Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1750-1172
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain ; volume:8 ; number:1 ; day:25 ; month:3 ; year:2013 ; pages:1-9 ; date:12.2013
Orphanet journal of rare diseases ; 8, Heft 1 (25.3.2013), 1-9, 12.2013

Urheber
Rombach, Saskia M.
Beteiligte Personen und Organisationen
Smid, Bouwien E.
Bouwman, Machtelt G.
Linthorst, Gabor E.
Dijkgraaf, Marcel G W.
Hollak, Carla E M.
SpringerLink (Online service)

DOI
10.1186/1750-1172-8-47
URN
urn:nbn:de:1111-2016050123793
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:49 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Rombach, Saskia M.
  • Smid, Bouwien E.
  • Bouwman, Machtelt G.
  • Linthorst, Gabor E.
  • Dijkgraaf, Marcel G W.
  • Hollak, Carla E M.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Cost-effectiveness of enzyme replacement therapy for Fabry disease

Cost-effectiveness of enzyme replacement therapy for Fabry disease

Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease

Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease

Impact of kidney biopsy on deciding when to initiate enzyme replacement therapy in children with Fabry disease

Impact of kidney biopsy on deciding when to initiate enzyme replacement therapy in children with Fabry disease

Detailed characterization of anti-drug antibodies against enzyme replacement therapy in Fabry disease

Hochschulschrift

Detailed characterization of anti-drug antibodies against enzyme replacement therapy in Fabry disease

Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy

Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy

Impact of enzyme replacement therapy on clinical manifestations in females with Fabry disease

Impact of enzyme replacement therapy on clinical manifestations in females with Fabry disease

Heart replacement, artificial heart

Konferenzschrift | Kongress

Heart replacement, artificial heart

Heart replacement, artificial heart 5

Konferenzschrift | Kongress

Heart replacement, artificial heart 5

Case report: enzyme replacement therapy for Fabry disease presenting with proteinuria and ventricular septal thickening

Case report: enzyme replacement therapy for Fabry disease presenting with proteinuria and ventricular septal thickening

Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment

Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

01.04 Non Invasive Evaluation of Arterial Remodeling in Patients with Fabry Disease after Enzyme Replacement Therapy

01.04 Non Invasive Evaluation of Arterial Remodeling in Patients with Fabry Disease after Enzyme Replacement Therapy

Verbundene Objekte